Compare SLS & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLS | FOA |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 183.8M |
| IPO Year | N/A | N/A |
| Metric | SLS | FOA |
|---|---|---|
| Price | $3.51 | $21.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $29.75 |
| AVG Volume (30 Days) | ★ 8.3M | 81.1K |
| Earning Date | 03-19-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $318,296,000.00 |
| Revenue This Year | N/A | $29.44 |
| Revenue Next Year | N/A | $14.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $16.58 |
| 52 Week High | $5.18 | $29.58 |
| Indicator | SLS | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 33.67 |
| Support Level | $3.66 | $22.86 |
| Resistance Level | $4.20 | $23.60 |
| Average True Range (ATR) | 0.42 | 0.87 |
| MACD | -0.14 | -0.21 |
| Stochastic Oscillator | 1.48 | 3.05 |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.